Related Experiment Video
Updated: Aug 18, 2026

Lung Tumor Cell Recruitment Assay
Published on: February 26, 2019
Midkine, a heparin-binding growth factor, produced by the host enhances metastasis of Lewis lung carcinoma cells
Ragaa H M Salama1, Hisako Muramatsu, Peng Zou
1Department of Biochemistry, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.
Abstract:
Midkine is a heparin-binding growth factor and is expressed by a number of tumor cells, contributing to their growth both in vitro and in vivo. Spontaneous lung metastasis of Lewis lung carcinoma cells, which did not significantly express MK, was significantly less extensive in mice deficient in the midkine gene than in wild-type mice, when the tumor was subcutaneously grown above the thigh. Midkine strongly enhanced migration of Lewis lung carcinoma cells in vitro. Therefore, midkine is also a host factor enhancing tumor metastasis. Anti-midkine therapy for malignancy may act on midkine produced by both the tumor and host.
Insights
Midkine (MK) promotes tumor growth and metastasis. Mice lacking the midkine gene showed reduced lung metastasis, indicating MK is a crucial host factor in cancer spread.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Midkine (MK) is a heparin-binding growth factor implicated in tumor cell proliferation.
- Tumor-expressed MK contributes to cancer growth both in vitro and in vivo.
Purpose of the Study:
- To investigate the role of midkine as a host factor in tumor metastasis.
- To evaluate the impact of midkine deficiency on spontaneous lung metastasis.
Main Methods:
- Utilized genetically modified mice deficient in the midkine gene.
- Subcutaneously implanted Lewis lung carcinoma cells in wild-type and midkine-deficient mice.
- Assessed spontaneous lung metastasis extent and in vitro cell migration.
Main Results:
- Mice deficient in midkine exhibited significantly reduced spontaneous lung metastasis compared to wild-type controls.
- Lewis lung carcinoma cells showed enhanced migration in vitro, which was strongly promoted by midkine.
- Midkine functions as a host factor that facilitates tumor cell migration and metastasis.
Conclusions:
- Midkine plays a significant role in promoting tumor metastasis, acting as a host factor.
- Targeting midkine, produced by both tumor and host cells, represents a potential therapeutic strategy for cancer treatment.
Related Concept Videos
Mitogens and the Cell Cycle
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...
The Tumor Microenvironment
